Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Biochem Pharmacol ; 224: 116206, 2024 06.
Article de Anglais | MEDLINE | ID: mdl-38615921

RÉSUMÉ

Long-chain fatty acyl-Coa ligase 4 (ACSL4) is an important enzyme that converts fatty acids to fatty acyl-Coa esters, there is increasing evidence for its role in carcinogenesis. However, the precise role of ACLS4 in hepatocellular carcinoma (HCC) is not clearly understood. In the present study, we provide evidence that ACSL4 expression was specifically elevated in HCC and is associated with poor clinical outcomes. ACSL4 significantly promotes the growth and metastasis of HCC both in vitro and in vivo. RNA sequencing and functional experiments showed that the effect of ACSL4 on HCC development was heavily dependent on PAK2. ACSL4 expression is well correlated with PAK2 in HCC, and ACSL4 even transcriptionally increased PAK2 gene expression mediated by Sp1. In addition, emodin, a naturally occurring anthraquinone derivative, inhibited HCC cell growth and tumor progression by targeting ACSL4. In summary, ACSL4 plays a novel oncogene in HCC development by regulating PAK2 transcription. Targeting ACSL4 could be useful in drug development and therapy for HCC.


Sujet(s)
Carcinome hépatocellulaire , Coenzyme A ligases , Évolution de la maladie , Tumeurs du foie , Souris nude , p21-Activated Kinases , Carcinome hépatocellulaire/anatomopathologie , Carcinome hépatocellulaire/génétique , Carcinome hépatocellulaire/métabolisme , Humains , Tumeurs du foie/anatomopathologie , Tumeurs du foie/métabolisme , Tumeurs du foie/génétique , p21-Activated Kinases/métabolisme , p21-Activated Kinases/génétique , Coenzyme A ligases/métabolisme , Coenzyme A ligases/génétique , Animaux , Souris , Mâle , Lignée cellulaire tumorale , Souris de lignée BALB C , Transcription génétique/effets des médicaments et des substances chimiques , Régulation de l'expression des gènes tumoraux , Émodine/pharmacologie , Femelle
2.
Food Chem ; 418: 135992, 2023 Aug 30.
Article de Anglais | MEDLINE | ID: mdl-37001349

RÉSUMÉ

Antioxidants are widely used in the fields of food, medicine, nutraceuticals, and cosmetics. Given their important roles in promoting and maintaining human health, a large number of antioxidants have been reported. Some antioxidant-related databases have been developed; however, the annotation of antioxidants and related information stored in existing databases is incomplete and requires more efficient retrieval methods. This study aimed to develop a manually curated comprehensive antioxidant database (AODB). Currently, it stores 56,666 small molecules tested for antioxidant activity, 1480 antioxidant peptides, and 998 antioxidant proteins, including their structures, names, antioxidant assay records, computable physicochemical and ADMET properties, and sources. AODB supports text search and mining, 2D and 3D chemical structure search, and BLAST-based protein sequence search, enabling users to retrieve antioxidant data quickly and easily. AODB, as a one-stop antioxidant database, can facilitate the exploration of antioxidants and potential applications. AODB is publicly available and updated annually at https://aodb.idruglab.cn/.


Sujet(s)
Antioxydants , Peptides , Humains , Antioxydants/composition chimique , Peptides/composition chimique , Protéines , Bases de données factuelles , Compléments alimentaires
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE